CClinicalTrials.gg
CompletedNCT05656677Updated Dec 19, 2022

Parental Involvement in Pain Reducing Measures

An interventional study of Passive parental involvement and Active parental involvement in Procedural Pain, Preterm Infants and Parents, sponsored by Insel Gruppe AG, University Hospital Bern. Completed at 1 site in Switzerland. Per ClinicalTrials.gov, last updated 2022-12-19.

Sponsored by Insel Gruppe AG, University Hospital Bern · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 1 month after the study started (first participant enrolled Oct 2019, registered Nov 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Sex
All
01

Study summary

This pilot study was conceptualised to determine the feasibility of involving parents via facilitated tucking or observing during painful procedures and to measure change in parental stress and infant pain. An additional purpose of this pilot study was to determine the size of the cohort of preterm infants needed for a larger trial, the time, and resources required for recruitment and data collection.

Read the detailed description

Objectives

In this pilot study, the aims were to determine the feasibility of whether pain behaviour in extremely and very preterm infants and perceived parental stress change when parents are involved in pain reducing measures, either actively, performing facilitated tucking or passively, observing the intervention, in comparison to the involvement of nurses only. In addition, the infant's pain reactivity and parental stress over three time points of measurement was of interest.

Methods

Extremely and very preterm infants in need of subcutaneous erythropoietin were randomly assigned to the two intervention groups. The intervention encompassed that one parent of each infant was involved during the painful procedure: Either parents executed facilitated tucking themselves or stood by, observing the procedure. Usual care involved that nurse executed facilitated tucking. All infants received 0.5ml of 30% oral glucose solution via cotton swab before the painful procedure. Infant pain was observed with the Bernese Pain Scale for Neonates (BPSN) and measured with the skin conductance algesimeter (SCA) before, during, and after the procedure. Parents' stress levels were measured before and after the painful procedure on the infant, using the Current Strain Short Questionnaire (CSSQ).

Feasibility of a subsequent trial was determined by assessing recruitment, measurement and active parental involvement. Quantitative data collection methods (i.e., questionnaires, algesimeter) were employed to determine the number of participants for a larger trial and measurement adequacy. Qualitative data (interviews) was employed to determine parents' perspectives of their involvement.

02

Conditions studied

  • Procedural Pain
  • Preterm Infants
  • Parents

Keywords

  • pain
  • stress
  • preterm infants
  • parents
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's enrollment of 20 is below the median of 84 across 1,689 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Insel Gruppe AG, University Hospital Bern is the lead sponsor of 724 studies on the registry; 177 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Premature infants born at the NICU concerned
  • Born between 24 0/7- 32 0/7 weeks of gestation, birthweight (bw) \<1250g
  • Infant in need of s.c. erythropoietin
  • Parents fluently speaking and writing in German
  • Written informed consent by parents

Exclusion criteria

Exclusion Criteria:

  • Premature infant with an umbilical artery pH measurement \<7.00 or asphyxia
  • Premature infant with life threatening malformations of the central nervous system
  • Premature infant with intracranial haemorrhage (even if not present at the start of the study)
  • Premature infant with any surgical intervention
  • Parents with substance abuse (i.e., methadone, heroin, etc.), as mentioned in the electronic patient documentation (EPD)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
20 participants (actual)

Study arms

  • No intervention
    Two nurses executing facilitated tucking (FT)

    Usual care

  • Active comparator
    One parent watching passively

    One parent watching passively the 2 nurses executing FT

    Behavioral: Passive parental involvement

  • Active comparator
    One parent actively involved

    One parent actively executing FT

    Radiation: Active parental involvement

Interventions

  • BehavioralPassive parental involvement

    One parent watching a procedural painful intervention, two nurses executing facilitated tucking

  • RadiationActive parental involvement

    One parent watching a procedural painful intervention and at the same time executing facilitated tucking

06

What researchers measure

Primary outcomes

  1. The main objective of this pilot study was to determine the feasibility of a larger, appropriately powered study

    Feasibility assessment included recruitment rate (dependent on resources and in-/exclusion criteria)

    Time frame: 1 year

  2. Percentage of questionnaire completion

    * Check percentage of questionnaires completed and withdrawals * Interview parents about the feasibility of participating three times

    Time frame: 1 year

  3. The pain and stress measurement over three time points were reviewed for feasibility

    -The research team was also interviewed about acceptance, applicability and feasibility of the validated BPSN, the SCA over three time points

    Time frame: 1 year

  4. The active parental involvement over three time points were reviewed for feasibility

    In semi-structured interviews, parents were asked about performing facilitated tucking or standing by as observers, acceptance, applicability and feasibility of the CSSQ and measurement over three time-points -The research team was also interviewed about active parental involvement

    Time frame: 1 year

Secondary outcomes

  1. The secondary interest of the study was to test for significant differences in parental stress between the two intervention and control group at three measurement points as well as infant pain.

    To determine infant pain, two research team nurses observed the infant by using the Bernese Pain Scale for Neonates (BPSN) in real time before (2-3 minutes), during and (2-3 and 10 minutes) after the s.c. injection. The two nurses independently assessed the physiological and behavioural pain items \[(18)\]. The BPSN is a multidimensional tool in German and has shown satisfactory psychometric properties among preterm and term infants (validity: r = 0.75; reliability: α=0.8) \[(18)\]. Skin Conductance Algesimeter (SCA) was installed before the s.c. injection until the last BPSN measurement. An electrocardiogram electrode (ECG) was placed on the sole of the foot to the left and right of the ankle of the preterm infant. An initial baseline was obtained. Subsequently, SCA pain measurement was continuous.

    Time frame: 1 year

07

Study locations

1 site
  • Inselspital
    Bern, 3010, Switzerland
08

References and documents

Individual participant data

Plan to share: Yes — Data collection of pain assessment

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05656677
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Responsible party
Sponsor
First posted
Dec 19, 2022
Start date
Oct 1, 2019
Primary completion
Nov 1, 2020
Completion
Nov 1, 2022
Last update
Dec 19, 2022

Study contacts

Sandra Zwakhalen, Prof. Dr.
study chair · Fac. Health, Medicine and Life Sciences, Health Services Research CAPHRI - University of Maastricht

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion